Relapse Remitting Multiple Sclerosis Clinical Trial
Official title:
A Randomized, Partially Blind, Placebo-controlled, Proof-of-concept Study to Assess the Effect of a Single Infusion of VAY736 on Disease Activity as Measured by Brain MRI Scans in Patients With Relapsing-remitting Multiple Sclerosis
This was a randomized, partially blinded, placebo-controlled, non-confirmatory study to assess the effects of a single infusion of VAY736 on disease activity as measured by brain MRI scans in patients with relapsing-remitting multiple sclerosis (RRMS).
The study was planned to be conducted in approximately 96 patients. However, after enrolling 8 patients, the recruitment was terminated based on strategic considerations. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00203112 -
Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline
|
Phase 2 | |
| Recruiting |
NCT04857489 -
Deficient T Regulatory Cell (Treg) Function in Patients With Relapsing Remitting Multiple Sclerosis
|
||
| Active, not recruiting |
NCT05084638 -
Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls.
|
Phase 4 | |
| Recruiting |
NCT05705986 -
Immunoregulatory Effect of Microparticle Delivered STING Agonist in the Control of Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)
|
||
| Completed |
NCT00203099 -
Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine
|
Phase 2 |